ArticleHuman vaccines & immunotherapeutics2025

Immunogenicity of a recombinant subunit COVID-19 vaccine: A prospective, multi-centre, longitudinal study in Chinese Alzheimer's disease patients.

Youhong Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.